Office of Research Assurances

Biosafety

Investigative New Animal Drug


Any investigator who plans to utilize an investigative new animal drug as part of their research should coordinate their communications with FDA through the ORA.

This communication is necessary to ensure that the appropriate waivers and exemptions with FDA Guidelines for Industry 170 "Animal Drug User Fees and Fee Waivers and Reductions" are applied. Also, any faculty member applying for an INAD or causing the FDA to open an existing INAD file (such as for a revision, etc…) significant fees may be incurred.

Office of Research Assurances, P.O. Box 643005, Albrook 205, Washington State University, Pullman WA 99164-3005
Phone: 509-335-7195, Fax: 509-335-6410, ibc@wsu.edu